Latest in Dermatology

Reuters Health • The Doctor's Channel Daily Newscast

Vast majority of patients with thin melanomas alive at 20 years: study

NEW YORK (Reuters Health) – The 20-year survival rate for people diagnosed with thin or T1 melanomas 1 mm thick or less, the most common type, is 96%, according to an analysis of data from the Queensland Cancer Registry. “We have confirmed that the outlook for patients with thin invasive melanomas is...

Reuters Health • The Doctor's Channel Daily Newscast

Diluted abobotulinum toxin A reduces wrinkles over larger area

NEW YORK (Reuters Health) – A small study comparing two concentrations of abobotulinum toxin A (brand name, Dysport) in reducing forehead wrinkles indicates that greater dilution results in a larger surface area of effect. The finding suggests that diluting the product “may allow clinicians to achieve...

Reuters Health • The Doctor's Channel Daily Newscast

Combination therapy seems best for relief of psoriasis: report

NEW YORK (Reuters Health) – To combat psoriasis, a combination of topical therapies seems to work better than topical monotherapy, according to results of a systematic review and meta-analysis of published research. “It is important to consider combination treatment in the armamentarium of psoriasis...

Actinic Keratosis

Sunscreen

Atrophoderma Vermiculatum

123